DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Lannutti BJ, Meadows SA, Herman SE. et al.
CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability.
Blood 2011;
117: 591-594
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.